IQVIA Holdings Inc (IQV)

170.56 +0.79  +0.47% NYSE Nov 23, 20:00 USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
02/12/2021 Earnings IQVIA Holdings Inc Fourth Quarter Earnings for 2020 Release
02/12/2021 09:00 EST Misc IQVIA Holdings Inc Fourth Quarter Earnings Conference Call for 2020
10/20/2020 Earnings IQVIA Holdings Inc Third Quarter Earnings Result for 2020
10/20/2020 09:00 EDT Misc IQVIA Holdings Inc Third Quarter Earnings Conference Call for 2020
07/22/2020 09:00 EDT Misc IQVIA Holdings Inc Second Quarter Earnings Conference Call for 2020
07/22/2020 Earnings IQVIA Holdings Inc Second Quarter Earnings Result for 2020
04/28/2020 09:00 EDT Misc IQVIA Holdings Inc First Quarter Earnings Conference Call for 2020
04/28/2020 Earnings IQVIA Holdings Inc First Quarter Earnings Result for 2020
04/06/2020 09:00 EDT Misc IQVIA Holdings Inc Annual General Meeting for 2019
02/18/2020 Misc IQVIA Holdings Inc Annual Report for 2019
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.iqvia.com
  • Investor Relations URL: http://ir.quintilesims.com/overview/default.aspx
  • HQ State/Province: Connecticut
  • Sector: Healthcare
  • Industry: Diagnostics & Research
  • Equity Style: Large Cap/Blend
  • Next Earnings Release: Feb. 12, 2021
  • Last Earnings Release: Oct. 20, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

Top Fund Holders

Symbol Name Weighting
BBH VanEck Vectors Biotech ETF 5.25%
FBT First Trust NYSE Arca Biotech ETF 3.48%
DUZRX Delaware US Growth R6 3.08%
LGMNX Loomis Sayles Global Allocation N 2.39%
IGAF.TO IA Clarington Global Allocation ETF 2.34%
MLRMX MainStay Winslow Large Cap Growth Simple 1.53%
VAFNX Invesco American Franchise R5 1.26%
AIO AllianzGI AI & Tech Opportunities Fund 1.25%
VMGIX Vanguard Mid-Cap Growth Index Investor 1.15%
VOT Vanguard Mid-Cap Growth ETF 1.15%
VIMSX Vanguard Mid Cap Index Investor 0.61%
VO Vanguard Mid-Cap ETF 0.61%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.